Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/67314
COMPARING HR-HPV SCREENFIRE HPV RISK STRATIFICATION TEST WITH SEEGENE ANYPLEX II HPV28 DETECTION
Author
Affilliation
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Sabin Laboratory and Institute. Brasília, DF, Brasil.
Sabin Laboratory and Institute. Brasília, DF, Brasil.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Sabin Laboratory and Institute. Brasília, DF, Brasil.
Sabin Laboratory and Institute. Brasília, DF, Brasil.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
National Cancer Institute. Division Of Cancer Epidemiology And Genetics. Rockville, MD, United States of America.
Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.
Share